GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE292nnn/GSE292343/primary200OKTranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292343GEOGSEfalseAn analysis of gemcitabine-resistant intrahepatic cholangiocarcinoma cellsIntrahepatic cholangiocarcinoma (iCCA) is an aggressive liver bile duct cancer with a poor prognosis. For advanced iCCA patients, Gemcitabine (GEM)-based chemotherapy is the standard treatment. Since there is only a 20-30% response rate for advanced CCA patients, it is a critical issue to counteract GEM resistance (GR). We selected two GR iCCA sublines (SSP-25-GR and KKU-213-GR) from the parental cells (SSP-25 and KKU-213) to determine the transcriptome profile.2026/09/16GSE292343GSM8856993GSM8856995GSM8856994GSM885699624676292343Homo sapiens[42708082]